Barrington raised the firm’s price target on Universal Technical (UTI) to $36 from $35 and keeps an Outperform rating on the shares after the company’s Q2 results came in above expectations and FY25 guidance was raised. The firm expects continued strong performance going forward, driven by Phase II of its North Star Strategy, which is expected to result in a five-year revenue compound annual growth rate of 10%, the analyst tells investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UTI:
